Widespread cutaneous necrosis associated with antiphospholipid antibodies: Report of four cases

Journal of Clinical Rheumatology

Volumn 8, Issue 6, 2002, Pages 326-331

  Rossini, José ^a   Roverano, Susana ^a   Graf, César ^a   Paira, Sergio ^a,b  

^a Hospital Jose M Cullen   (Argentina)

^b Crespo 2752 ^*  (Argentina)

Author keywords

Antiphospholipid antibodies; Vascular thrombosis; Widespread cutaneous necrosis

Indexed keywords

ACENOCOUMAROL; ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; CALCIUM; HEPARIN; HYDROXYCHLOROQUINE; ISONIAZID; PHOSPHOLIPID ANTIBODY; PREDNISONE; VITAMIN D;

ADOLESCENT; ADULT; ANTIBODY DETECTION; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CASE REPORT; CLINICAL FEATURE; EARLY DIAGNOSIS; FEMALE; HUMAN; LONG TERM CARE; MALE; ONSET AGE; PRIORITY JOURNAL; SKIN BIOPSY; SKIN NECROSIS; SYNDROME DELINEATION; THROMBOSIS; WOUND HEALING;

EID: 0036900548     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/00124743-200212000-00009     Document Type: Article

References (27)

1. Hughes GRV. Thrombosis, abortion, cerebral disease and lupus anticoagulant. BMJ 1983;283:1088-9.
2. Asherson RA, Khamashta MA, Ordi-Ros J, et al. The "primary" antiphospholipid syndrome: Major clinical and serological features. Medicine 1989;68:366-74.
3. Alarcon-Segovia D, Sanchez-Guerrero J. Primary antiphospholipid syndrome. J Rheumatol 1989;16:482-8.
4. Asherson RA, Cervera R. Antiphospholipid syndrome. J Invest Dermatol 1993;100:21-7.
5. Stephansson EA, Niemi KM, Jouhikainen T, et al. Lupus anticoagulant and the skin. A long-term follow-up of SLE patients with special reference to histopathological findings. Acta Derm Venereol 1991;71:416-2.
6. Alegre VA, Gastineau DA, Winkelmann RK. Skin lesions associated with circulating lupus anticoagulant. Br J Dermatol 1989;120:419-29.
7. Dodd HJ, Sarkany I, O'Shaughnessy D. Widespread cutaneous necrosis associated with the lupus anticoagulant. Clin Exp Dermatol 1985;10:581-6.
8. Paira SO, Roverano S, Zunino A, et al. Extensive cutaneous necrosis associated with anticardiolipin antibodies. J Rheumatol 1999;26:1197-2000.
9. Frances C, Tribout B, Boisnic S, et al. Cutaneous necrosis associated with the anticoagulant. Dermatologica 1989;178:194-201.
10. Amster MS, Conway J, Zeid M, et al. Cutaneous necrosis resulting from protein S deficiency and increased antiphospholipid syndrome in a patient with systemic lupus erythematosus. J Am Acad Dermatol 1993;29: 853-7.
11. Creamer C, Hunt BJ, Black MM. Widespread cutaneous necrosis occurring in association with the antiphospholipid syndrome: A report of two cases. Br J Dermatol 2000;142:1199-203.
12. Fiehn C, Breitbart A, Germann G. Autologous skin transplantation for widespread cutaneous necrosis in secondary antiphospholipid syndrome. Ann Rheum Dis 2001;60:908-10.
13. Jou IM, Liu MF, Chao SC. Widespread cutaneous necrosis associated with antiphospholipid syndrome. Clin Rheumatol 1996;15:394-8.
14. Abernethy MC, Me Guinn JL, Callen JP. Widespread cutaneous necrosis as the initial manifestation of the antiphospholipid syndrome. J Rheumatol 1995;22:1380-3.
15. Del Castillo L, Soria C, Schoendorff C, et al. Widespread cutaneous necrosis and antiphospholipid antibodies: Two episodes related to surgical manipulation and urinary tract infection. J Am Acad Dermatol 1997;36:872-5.
16. Soweid AM, Hajjar RR, Hewan-Lowe KO, et al. Skin necrosis indicating antiphospholipid syndrome in a patient with AIDS. South Med J 1995;88:786-8.
17. Wolf P, Soyer HP, Auer-Grumbach P, et al. Widespread cutaneous necrosis in a patient with rheumatoid arthritis associated with anticardiolipin antibodies [letter]. Arch Dermatol 1991;127:1739-40.
18. Hill VA, Whittaker SJ, Hunt BJ, et al. Cutaneous necrosis associated with the antiphospholipid syndrome and mycosis fungoides. Br J Dermatol 1994;130:92-6.
19. O'Neill A, Gatenby PA, Me Graw B, et al. Widespread cutaneous necrosis associated with cardiolipin antibodies. J Am Acad Dermatol 1990;22:356-9.
20. Joseph J, Scopelitis E. Seronegative antiphospholipid syndrome associated with plasminogen activator inhibitor. Lupus 1994;3:201-3.
21. Asherson RA, Cervera R, Lie JT. The antiphospholipid syndromes. In: Lahita RB, editor. Systemic Lupus Erythematosus. New York: Academic Press, 1999;829-70.
22. Carreras LO, Defreyn G, Machin SJ, et al. Arterial thrombosis, intrauterine death, and lupus anticoagulant: Detection of immunoglobulin interfering with prostacyclin formation. Lancet 1981;1:244-6.
23. Freyssinet JM, Cazenave JP. Lupus-like anticoagulants: Modulation of the protein C pathway and thrombosis. Thromb Haemost 1987;58:679-81.
24. Keeling DM, Campbell SJ, Mackie IJ, et al. The fibrinolytic response to venous occlusion and natural anticoagulants in patients with antiphospholipid antibodies both with and without systemic lupus erythematosus. Br J Haematol 1991;77:354-9.
25. Cervera R, Khamashta MA, Font J, et al. Antiendothelial cell antibodies in patients with the antiphospholipid syndrome. Cell Autoimmunity 1991;11:1-6.
26. Frances C, Piette JC. Cutaneous manifestations of Hughes syndrome occurring in the context of lupus erythematosus. Lupus 1997;6:139-44.
27. Khamashta MA, Cuadrado MJ, Mujic M, et al. The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med 1995;332:993-7.